HLN
HaleonCNYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
Bull thesis: sustained organic growth, clear margin progress from cost programs, and favorable analyst revisions drive multiple expansion toward the analyst high (~$14.39). Execution on product launches and pricing would crystallize this upside.
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +10.3.
What can break
Demand softness in OTC categories or SKU delistings
Momentum
26
Value
52
Sentiment
85
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $11.39 · Bull $14.39 · Bear $8.99
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-02-06 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $11.58
Why
Momentum26 · Δ7d -1.5
Value52 · Δ7d +0.0
Sentiment85 · Δ7d +10.3
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Sentiment · See AI snapshot
Momentum
26
34% active weight
Current posture
7d trendFlat
Δ7d
-1.5
Δ21d
+6.8
Value
52
32% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
+0.0
Sentiment
85
33% active weight
Current posture
7d trendImproving
Δ7d
+10.3
Δ21d
+11.7
Why this grade
Composite grade C. Momentum 25.6 / Value 52.3 / Sentiment 84.8
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$38.89B
Beta
0.39
Shares Out
8.91B
P/E (TTM) · Derived
8.9
P/S (TTM)
-
P/FCF (TTM)
23.47
Rev YoY
-0.3%
EPS YoY
+7965.6%
Gross Margin
+60.7%
Op Margin
+19.6%
Net Debt
$10.14B
Current Ratio
0.87
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology